BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11426550)

  • 1. The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphoma.
    White JD; Wharfe G; Stewart DM; Maher VE; Eicher D; Herring B; Derby M; Jackson-Booth PG; Marshall M; Lucy D; Jain A; Cranston B; Hanchard B; Lee CC; Top LE; Fleisher TA; Nelson DL; Waldmann TA
    Leuk Lymphoma; 2001 Jan; 40(3-4):287-94. PubMed ID: 11426550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma.
    Hermine O; Allard I; Lévy V; Arnulf B; Gessain A; Bazarbachi A;
    Hematol J; 2002; 3(6):276-82. PubMed ID: 12522449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine.
    Gill PS; Harrington W; Kaplan MH; Ribeiro RC; Bennett JM; Liebman HA; Bernstein-Singer M; Espina BM; Cabral L; Allen S
    N Engl J Med; 1995 Jun; 332(26):1744-8. PubMed ID: 7760890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa.
    Guery R; Suarez F; Lanternier F; Bougnoux ME; Lecuyer H; Avettand-Fenoel V; Sibon D; Frenzel L; Raphalen JH; Helias P; Renaudier P; Santa F; Lecuit M; Lortholary O; Hermine O; Aguilar C; Marçais A
    Ann Hematol; 2021 Nov; 100(11):2813-2824. PubMed ID: 34387741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes.
    Bazarbachi A; Plumelle Y; Carlos Ramos J; Tortevoye P; Otrock Z; Taylor G; Gessain A; Harrington W; Panelatti G; Hermine O
    J Clin Oncol; 2010 Sep; 28(27):4177-83. PubMed ID: 20585095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).
    Kchour G; Tarhini M; Kooshyar MM; El Hajj H; Wattel E; Mahmoudi M; Hatoum H; Rahimi H; Maleki M; Rafatpanah H; Rezaee SA; Yazdi MT; Shirdel A; de Thé H; Hermine O; Farid R; Bazarbachi A
    Blood; 2009 Jun; 113(26):6528-32. PubMed ID: 19411628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma.
    Hermine O; Dombret H; Poupon J; Arnulf B; Lefrère F; Rousselot P; Damaj G; Delarue R; Fermand JP; Brouet JC; Degos L; Varet B; de Thé H; Bazarbachi A
    Hematol J; 2004; 5(2):130-4. PubMed ID: 15048063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphoma.
    Cook LB; Rowan AG; Demontis MA; Sagawe S; Gillet NA; Melamed A; Greiller C; Witkover A; Bangham CRM; Taylor GP
    Int J Hematol; 2018 Mar; 107(3):378-382. PubMed ID: 29090417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients.
    Matutes E; Taylor GP; Cavenagh J; Pagliuca A; Bareford D; Domingo A; Hamblin M; Kelsey S; Mir N; Reilly JT
    Br J Haematol; 2001 Jun; 113(3):779-84. PubMed ID: 11380470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon alfa and antiretroviral agents: a treatment option for adult T-cell leukemia/lymphoma.
    Ishitsuka K; Tsukasaki K; Tamura K
    Drugs Today (Barc); 2011 Aug; 47(8):615-23. PubMed ID: 21850284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients.
    Bazarbachi A; Hermine O
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S186-90. PubMed ID: 8797722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma.
    Hodson A; Crichton S; Montoto S; Mir N; Matutes E; Cwynarski K; Kumaran T; Ardeshna KM; Pagliuca A; Taylor GP; Fields PA
    J Clin Oncol; 2011 Dec; 29(35):4696-701. PubMed ID: 22042945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of Targeted Therapies for Adult T-Cell Leukemia/Lymphoma.
    Nasr R; Marçais A; Hermine O; Bazarbachi A
    Methods Mol Biol; 2017; 1582():197-216. PubMed ID: 28357672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of adult T-cell leukemia-lymphoma by CHOP followed by therapy with antinucleosides, alpha interferon and oral etoposide.
    Besson C; Panelatti G; Delaunay C; Gonin C; Brebion A; Hermine O; Plumelle Y
    Leuk Lymphoma; 2002 Dec; 43(12):2275-9. PubMed ID: 12613513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphoma.
    Bazarbachi A; Nasr R; El-Sabban ME; Mahé A; Mahieux R; Gessain A; Darwiche N; Dbaibo G; Kersual J; Zermati Y; Dianoux L; Chelbi-Alix MK; de Thé H; Hermine O
    Leukemia; 2000 Apr; 14(4):716-21. PubMed ID: 10764160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109).
    Tsukasaki K; Tobinai K; Shimoyama M; Kozuru M; Uike N; Yamada Y; Tomonaga M; Araki K; Kasai M; Takatsuki K; Tara M; Mikuni C; Hotta T;
    Int J Hematol; 2003 Feb; 77(2):164-70. PubMed ID: 12627852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide (As
    Marçais A; Cook L; Witkover A; Asnafi V; Avettand-Fenoel V; Delarue R; Cheminant M; Sibon D; Frenzel L; de Thé H; Bangham CRM; Bazarbachi A; Hermine O; Suarez F
    Retrovirology; 2020 Mar; 17(1):5. PubMed ID: 32199462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: a randomized phase II study from the Nordic Lymphoma Group.
    Kimby E; Jurlander J; Geisler C; Hagberg H; Holte H; Lehtinen T; Ostenstad B; Hansen M; Osterborg A; Lindén O; Sundström C;
    Leuk Lymphoma; 2008 Jan; 49(1):102-12. PubMed ID: 18203019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Jurkat T Lymphocyte Leukemia Cells by an Engineered Interferon-Alpha Hybrid Molecule.
    Yu D; Du Z; Li W; Chen H; Ye S; Hoffman AR; Cui J; Hu JF
    Cell Physiol Biochem; 2017; 42(2):519-529. PubMed ID: 28578326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa.
    Hermine O; Bouscary D; Gessain A; Turlure P; Leblond V; Franck N; Buzyn-Veil A; Rio B; Macintyre E; Dreyfus F
    N Engl J Med; 1995 Jun; 332(26):1749-51. PubMed ID: 7760891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.